MLMaya Ya. Lafarenko

Maya Ya. Lafarenko

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Maya Ya. Lafarenko has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    ANALYSIS OF THE RELATIONSHIPS OF FOLATE METABOLISM PARAMETERS, VITAMIN D STATUS, AND MTHFR GENE VARIANTS WITH THE CLINICAL FEATURES OF MULTIPLE SCLEROSIS

    by Tetyana I. Nehrych, Maya Ya. Lafarenko, Nazar O. Nehrych, Zoia I. Rossokha, Liliia Ye. Fishchuk, Nataliia G. Gorovenko, Тетяна І. Негрич, Зоя І. Россоха, Лілія Є. Фіщук

    Introduction. Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system characterized by demyelination and neurodegeneration. Emerging evidence suggests a potential role of folate metabolism, vitamin D status, and MTHFR gene polymorphisms in MS pathogenesis and progression. In populations without food fortification, such as Ukraine, these factors may be particularly relevant, highlighting the need to study their interrelationships with clinical disease features. Aim. To investigate the relationship between folate metabolism markers (homocysteine, folic acid, and vitamin B12), vitamin D levels, MTHFR gene variants, and the clinical characteristics of disease progression in patients with MS. Materials and methods. This study assessed biochemical markers of folate metabolism (homocysteine, folic acid, vitamin B₁₂), vitamin D levels, and the MTHFR rs1801133 genotype in 113 MS patients, with in-depth biochemical analysis conducted in a randomly selected subgroup of 36 patients. Clinical and demographic data were collected, and statistical analyses were performed to evaluate correlations between biochemical, genetic, and clinical parameters. Results. Patients demonstrated elevated median homocysteine levels and suboptimal concentrations of folic acid, vitamin B₁₂, and vitamin D. Significant inverse correlations were observed between homocysteine and folic acid levels, as well as between vitamin D levels and EDSS scores. Smokers had significantly lower vitamin B₁₂ levels. Although the difference was not statistically significant, patients with the TT genotype of MTHFR rs1801133 showed a trend toward lower folic acid levels. Homocysteine levels were highest in patients with secondary progressive MS, indicating a possible link to disease progression. Conclusions. Findings highlight the potential contribution of disrupted folate metabolism and vitamin D deficiency to MS pathogenesis, particularly in populations lacking food fortification. These results underscore the need for further research into vitamin-based interventions as possible strategies for modifying disease course.

  • Open Access

    Assessment of psycho-emotional disorders in patients with multiple sclerosis

    by T.I. Nehrych, M.YA. Lafarenko, Т.і. Негрич

    Objective — to determine the prevalence and nature of depressive and anxiety disorders in patients with multiple sclerosis, as well as to assess their impact on the clinical course of the disease, overall health status, and cognitive functions. Materials and methods. The study included 103 patients diagnosed with MS, observed in an outpatient setting. The Patient Health Questionnaire-9 (PHQ-9), Beck Depression Inventory (BDI), and Hospital Anxiety and Depression Scale (HADS) were used for psychological assessment. Disability level was assessed using the Expanded Disability Status Scale (EDSS). Data were analyzed using descriptive and inferential statistical methods. Results and discussion. Depressive symptoms of varying severity were identified in 40.78 % of participants. A significant portion also had elevated anxiety scores on the HADS. There were no statistically significant differences based on age or gender. However, a clear correlation was observed between more severe depressive symptoms and higher EDSS scores. Patients with anxiety and depressive disorders frequently reported decreased concentration, memory, and cognitive performance, suggesting an emotional impact on cognitive function. Conclusions. Psycho-emotional disturbances are common in MS patients and negatively affect disease progression, disability level, and quality of life. The findings support the integration of regular psychological screening into standard MS care protocols to ensure timely detection and treatment of emotional disorders, which may lead to better clinical outcomes.

  • Open Access

    THE IMPACT OF VARIANTS OF THE MTHFR (rs1801133, rs1801131) AND RFC (rs1051266) GENES AND THEIR COMBINATIONS ON THE RISK AND PROGRESSION OF MULTIPLE SCLEROSIS

    by Tetyana Nehrych, Maya Lafarenko, Nazar Nehrych, Zoya Rossokha, Liliya Fishchuk, Nataliia Gorovenko

    Aim. Impairments in folate cycle function may play a role in the pathogenesis of multiple sclerosis (MS). Genetic variants of folate metabolism enzymes and transporters, particularly MTHFR (rs1801133, rs1801131) and RFC (rs1051266), may modulate the risk of MS development and its clinical course. Objective. To determine the impact of variants of the MTHFR (rs1801133, rs1801131) and RFC (rs1051266) genes, as well as their combinations, on the risk, progression, and potential prediction of neurological damage in MS, with a view toward identifying new preventive therapeutic strategies. Materials and Methods. The study included 113 MS patients and 70 healthy controls. Genotyping was performed using a polymerase chain reaction with restriction fragment length polymorphism analysis. Clinical evaluation included assessment of the Expanded Disability Status Scale (EDSS) score. Results. The 1298C allele of MTHFR (rs1801131) was associated with an increased risk of MS, while the 1298A allele had a protective effect. Additionally, the 80A allele and 80GA genotype of RFC (rs1051266) were linked to a higher risk of MS, whereas the 80G allele and 80GG genotype exhibited a protective effect. In patients with the 80GA genotype, the EDSS score was significantly lower compared to those with the 80GG and 80AA genotypes. A combined effect of variants of the MTHFR and RFC genes was identified, modifying the risk of MS and its clinical manifestations. Conclusions. Genetic variants of MTHFR (rs1801131) and RFC (rs1051266) impact the risk of developing and the course of MS. The combination of genotypes 1298AC+80GA was associated with an increased risk of MS, whereas 80GG, in combination with functionally favorable MTHFR variants, reduced this risk.


  • Open Access

    Thoracic myelopathy in plasmacytoma: a case report

    by M.YA. Lafarenko, Kh.V. Perkun, S.B. Chornobai, O.-R.V. Lafarenko

    This article presents a clinical case of extramedullary plasmacytoma of the thoracic wall, which led to the development of multiple myelopathy and caused compressive spinal cord injury at the Th10 level. The clinical manifestations of the disease are described, including progressive lower spastic paraparesis with impaired pelvic organ function. A comprehensive diagnostic evaluation was conducted using neuroimaging methods (magnetic resonance imaging, computed tomography), morphological studies (soft tissue and bone marrow biopsy), and consultations with a multidisciplinary team of specialists. The patient underwent a course of radiation therapy, which contributed to partial regression of the tumor process, as well as symptomatic and neuroprotective therapy, leading to improved lower limb motor activity, reduced hypoesthesia, and restoration of bladder function. This case highlights the necessity of early diagnosis of tumors of the spine and bone marrow, as timely intervention can significantly improve the prognosis. Moreover, this clinical case underscores the importance of a multidisciplinary approach in managing patients with oncohematological pathology complicated by neurological disorders.

  • Open Access

    Assessment of depression and anxiety in patients with multiple sclerosis depending on disease severity according to the EDSS

    by M.YA. Lafarenko

    Background. The study was aimed at analyzing the impact of multiple sclerosis (MS) severity according to the Expanded Disability Status Scale (EDSS) on the physical and psycho-emotional state of patients, in particular on the level of depression, anxiety and self-assessment of health status. Objective: to determine the features of the psycho-emotional and physical state of patients with MS depending on disease severity on the EDSS and using standardized depression and anxiety assessment scales. Materials and methods. The cohort comprised 103 individuals with a confirmed MS diagnosis, categorized into three groups based on EDSS-assessed severity: mild (n = 54), moderate (n = 31), and severe (n = 18). Psychological state was assessed using the Hospital Anxiety and Depression Scale, the Beck Depression Inventory, and the Patient Health Questionnaire-9. Results. Patients with mild MS predominantly rated their health as good, whereas those with mo-derate MS frequently reported a fair condition, and individuals with severe MS commonly identified their health as poor. Notably, the highest median depression scores (10.5 [7; 11] points) and prevalence of clinically significant depression (50.00 %) were observed in the severe MS group. Subclinical anxiety was disproportionately prevalent among patients with moderate MS (35.48 %) compared to those with mild MS (14.81 %). The analysis revealed distinct trajectories for depression and anxiety depending on disease severity, with psychological distress intensifying in tandem with MS progression. Conclusions. The findings underscore the critical necessity of integrating MS severity into holistic assessments of physical and psycho-emotional health. The data advocate for comprehensive treatment paradigms encompassing both medical interventions and targeted psychosocial support to ameliorate depression, anxiety, and fatigue. These insights establish a framework for advancing personalized therapeutic strategies in MS management.

  • Open Access

    THE 4A/B POLYMORPHISM OF THE NOS3 GENE AS A PREDICTOR OF SUSCEPTIBILITY AND PROGRESSION OF MULTIPLE SCLEROSIS

    by Maya Lafarenko, Nazar Nehrych, Liliya Fishchuk, Olena Popova, Zoya Rossokha, Tetyana Nehrych

    Aim. Nitric oxide (NO) and the variants of the endothelial nitric oxide synthase gene (NOS3) in multiple sclerosis (MS) have become a focus of active scientific interest in recent years. The NOS3 gene is constitutively expressed in neuronal and epithelial cells. Moreover, the endothelial NO synthase enzyme (eNOS) activity, which plays a pivotal role in developing endothelial dysfunction, is regulated by variants of the NOS3 gene, including the 4a/b variant. Objective. To evaluate the influence of the 4a/b variant of the NOS3 gene on the susceptibility to and progression of multiple sclerosis. Materials and Methods. The study included 113 patients diagnosed with MS. Genotyping for the 4a/b variant of the NOS3 gene was performed using the polymerase chain reaction method. Results. Our findings indicate that the presence of the 4bb genotype is associated with a reduced risk of developing MS, whereas the 4a allele of the NOS3 gene is linked to an increased risk. Clinical characteristic analysis revealed that patients with the 4ba and 4bb genotypes exhibited a significantly higher body mass index (BMI) (p=0.007) than those with the 4aa genotype. Additionally, patients with the 4bb genotype were substantially more likely to experience a severe disease course (p=0.0489). Binary logistic regression analysis identified a gene-environment interaction between the NOS3 4a/b variant and BMI (p=0.037), suggesting a combined effect of these factors on MS progression. Conclusions. The results underscore the significant and complex role of the NOS3 4a/b variant in the pathogenesis and progression of MS. Further investigation is warranted to deepen our understanding of the mechanisms underlying this genetic factor and its interplay with other contributing variables.


  • Open Access

    Familial cases of multiple sclerosis: gender differences and clinical course

    by T.I. Nehrych, M.YA. Lafarenko

    Background. This study focuses on analyzing the progression of multiple sclerosis (MS) across different familial and age cohorts to determine gender-specific trends in disease onset, progression, and severity. Objective: to determine gender-specific regularities in the course of MS based on the analysis of mean age of onset, disease duration, and level of disability (on the Expanded Disability Status Scale (EDSS)) in family clusters. Materials and methods. A cohort of 10 family (20 individuals, 16 women and 4 men) was studied. Analysis encompassed older (9 women, 1 man) and younger family members (7 women, 3 men). In addition, a comparative analysis was conducted by age according to the World Health Organization criteria: young patients (9 women, 4 men) and middle-aged patients (7 women). Results. The study confirmed a higher prevalence of MS among women within familial clusters. Specifically, the average age of MS onset among women was 34.67 years, which was higher compared to men (26 years). Analysis of EDSS scores revealed significant gender differences, with men having an average score of 6.0 indicating higher disability levels that in women who had an average score of 3.44. Younger patients (up to 44 years old) exhibited earlier onset and shorter disease duration compared to middle-aged patients (44 to 59 years), who tended to have later disease onset and higher EDSS scores, indicative of more severe disability. Young men with MS showed later disease onset and higher average EDSS scores, reflecting more pronounced disability than in young women who had earlier disease onset but lower EDSS scores. Conclusions. The findings highlight substantial gender-specific differences in the course of MS, which should be taken into account in the clinical management of patients. These results provide a foundation for further research and development of personalized approaches to the treatment and prevention of MS.